×

Stocks Pfizer Inc

  • Stocks advanced Monday as prospects for a resolution to the Greek debt crisis somewhat brightened and AIG agreeing to sell its Asian business to UK insurer Prudential.

  • They looked like hot stocks. So how are the traders playing Qualcomm, Amgen and more now that they’ve been burned?

  • Cost of healthcare

    Big pharmaceutical companies have been raising prices on a lot of drugs recently. Some critics say the industry's trying to cash in before government price controls possibly get put into place.

  • Cramer takes the pulse of the ticker, midday.

  • On a day when the market seemed confused - moving within relatively a wide range and ending the day to the downside - there were many reasons why this confusion was warranted.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Markets barely edged upward on Monday as Europe debt worries continue. Where are the best places to put your money now? Greg Merlino, president and founder of Ameriway Financial Services, and Ethan Anderson, portfolio manager at Rehmann Financial, shared their market strategies.

  • Forget Goldman Sachs, if you’re looking for hot stocks we’ve found a brokerage that’s currently the best in the business!

  • After the bell, the traders sifted through the latest results from Cisco. Is it safe to say the strong results bode well for the rest of the sector?

  • Stocks snapped a two-day winning streak Wednesday after tepid reports on employment and the services sector. Pfizer, Merck and Home Depot were the biggest decliners on the Dow.

  • On Wednesday, disappointing earnings sent investors running for the exits stopping a comeback dead in its tracks. Is the correction back; what should you be watching?

  • Stocks struggled Wednesday after tepid reports on employment and the services sector.

  • The ADP report for January, at a loss of 22,000 jobs (consensus was for a loss of 30,000), was the smallest decline since January 2008, which was the last time there was jobs growth. Then there's dividends — lots of dividends.

  • Stocks were set to ease slightly at the opening, following the S&P's best two-day gain since October. But numbers on the employment landscape will likely dictate early sentiment.

  • Traders on the floor of the New York Stock Exchange gather around a Bank of America trading post just prior to the announcement by the Federal Reserve that it had raised a key interest rate for the twelfth consecutive time, Tuesday, November 1, 2005. The Federal Reserve, still concerned about inflation, raised the interest rate to the highest level in more than four years and signaled more increases are likely.  (AP Photo/Henny Ray Abrams)

    Stocks on Wall Street could be put to the test Wednesday, after the market notched its best two-day gain in four months.

  • Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • Stocks turned a shaky start into a full-throttle rally Tuesday as UPS delivered an encouraging earnings report, pending home sales rose and Ford reported a double-digit increase in sales.

  • Nearly every city and state wants biopharma. They fiercely compete for the relatively clean industry and the well-paid, highly educated jobs it brings.

  • The week started out with nothing but good looking news. Overseas a bunch of countries reported their Purchasing Managers surveys (PMI) and they were almost uniformly good.

  • Pfizer headquarters in New York City.

    Pfizer, the world's largest drugmaker, is scheduled to report fourth-quarter results before the opening bell on Wednesday, February 3. Here is a look at how Pfizer shares traded during the most recent earnings reports.